Literature DB >> 4629118

The effect of tolbutamide and glibenclamide on the incorporation of ( 3 H)leucine and on the conversion of proinsulin to insulin in isolated pancreatic islets.

H Schatz, V Maier, M Hinz, C Nierle, E F Pfeiffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4629118     DOI： 10.1016/0014-5793(72)80581-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  8 in total

1.  Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN).

Authors:  H P Ammon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets.

Authors:  P Schauder; H Frerichs
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

3.  Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level.

Authors:  C Alarcon; B Wicksteed; C J Rhodes
Journal:  Diabetologia       Date:  2006-10-20       Impact factor: 10.122

4.  Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrations.

Authors:  L A Håkan Borg; A Andersson
Journal:  Acta Diabetol Lat       Date:  1981

5.  Insulin secretion and (pro)insulin biosynthesis of cultured mice islets after glibenclamide loading in vitro.

Authors:  B Ziegler; B Wilke; M Ziegler; S Schmidt; H Zühlke
Journal:  Experientia       Date:  1980-04-15

6.  Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.

Authors:  S D Garcia; C Jarrousse; G Rosselin
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

7.  Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways.

Authors:  Q Wang; H Heimberg; D Pipeleers; Z Ling
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

8.  Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets.

Authors:  S Kawazu; A Sener; E Couturier; W J Malaisse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-07       Impact factor: 3.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.